Schroth and Pilates Exercises in Idiopathic Adolescent Scoliosis
Launched by IZMIR KATIP CELEBI UNIVERSITY · Jan 17, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two types of exercise programs—Schroth and Pilates—to see how they help teenagers with adolescent idiopathic scoliosis (AIS), a condition where the spine curves and twists during growth. The study aims to find out if these exercises can improve breathing, balance, walking ability, spine shape, and overall quality of life. Schroth exercises focus on actively correcting the spine’s position through specific muscle contractions, while Pilates emphasizes improving flexibility, strength, posture, and breathing.
Teenagers aged 10 to 18 with a mild to moderate spine curve (measured as a Cobb angle between 10 and 25 degrees) may be eligible to join. Participants will be randomly assigned to either the Schroth or Pilates group and will attend supervised exercise sessions lasting one hour, three times a week, for eight weeks. Throughout the study, researchers will measure changes in spine curvature, lung function, balance, and quality of life. This trial is important because it could help identify effective, non-surgical ways to manage scoliosis and improve daily function for adolescents living with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • having a Cobb angle between 10 and 25 degrees
- • age between 10-18 years
- Exclusion Criteria:
- • Presence of secondary scoliosis (congenital, muscular and neurological scoliosis)
- • Presence of any cardiovascular and pulmonary disease that will prevent respiratory functions
- • Having a history of thoracic surgery
- • Use of assistive devices
- • Presence of a secondary orthopedic problem
About Izmir Katip Celebi University
Izmir Katip Celebi University is a prominent academic institution in Turkey, dedicated to advancing medical research and education. The university is committed to fostering innovation and excellence in clinical trials, leveraging its state-of-the-art facilities and a multidisciplinary team of experienced researchers and healthcare professionals. With a focus on improving patient outcomes and contributing to the global body of medical knowledge, Izmir Katip Celebi University actively engages in collaborative research initiatives, aiming to address critical health challenges through rigorous scientific inquiry and ethical practices in clinical trial management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İzmir, , Turkey
Izmir, , Turkey
Patients applied
Trial Officials
sevtap gunay ucurum
Principal Investigator
İzmir Katip Çelebi University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported